Patents by Inventor Chung Wei

Chung Wei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220263329
    Abstract: The present disclosure relates to a charger and a charger system, a charger having a removeable cover, as well as particular charger and adapter engagement configurations that provide robust, operative, and resealable association between the charger and adapter. The present disclosure also provides users the ability to forego a fixed, factory-provided aesthetic appearance of their chargers by providing the ability to customize the charger in accordance with an end-user's own preference/style.
    Type: Application
    Filed: February 18, 2022
    Publication date: August 18, 2022
    Applicant: Volonic, Inc.
    Inventors: Chung Wei, David Danielson, Shawn Dougherty
  • Publication number: 20080045709
    Abstract: The present invention provides a method to make a pyrrole substituted 2-indolinone compound of the formula
    Type: Application
    Filed: July 18, 2007
    Publication date: February 21, 2008
    Inventors: Huiping Guan, Congxin Liang, Li Sun, Peng Cho Tang, Chung Wei, Tomas Vojkovsky, Qingwu Jin, Paul Herrinton, Michael Mauragis
  • Publication number: 20070010569
    Abstract: The present invention relates to pyrrole substituted-2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
    Type: Application
    Filed: September 6, 2006
    Publication date: January 11, 2007
    Inventors: Peng Tang, Todd Miller, Xiaoyuan Li, Li Sun, Chung Wei, Shahrzad Shirazian, Congxin Liang, Tomas Vojkovsky, Asaad Nematalla, Michael Hawley
  • Publication number: 20060009493
    Abstract: The present invention relates to compounds of the formulae (I)-(XII), wherein R1-R71, A, B, X, Y, G, L and Z are defined herein, and their pharmaceutically acceptable salts. These compounds modulate the activity of c-Met and are therefore expected to be useful in the prevention and treatment of c-Met related disorders such as cancer.
    Type: Application
    Filed: June 25, 2004
    Publication date: January 12, 2006
    Inventors: Marcel Koenig, Jingrong Cui, Chung Wei, Steven Do, Fang-Jie Zhang, Tomas Vojkovsky, John Ramphal, Guang Yang, Matthew Mattson, Christopher Nelson, Peng Tang
  • Publication number: 20050032871
    Abstract: The present invention relates to compounds having the following chemical structure (Formula I): where the substituents R1-R10 are defined herein. The compounds of this invention are useful in treating disorders related to abnormal kinase activity. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds and methods of preparing them are also disclosed.
    Type: Application
    Filed: September 3, 2003
    Publication date: February 10, 2005
    Inventors: Peng Tang, Chung Wei, Yi Xia
  • Patent number: D1047902
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: October 22, 2024
    Assignee: Volonic, Inc.
    Inventors: Chung Wei, David Danielson, Shawn Dougherty